Startupsby GlyphWhy it ranks
How the rank works7signal of 100 · rising 1
- went through YCProgram · this site+4
- team of 2Team size · YC's directory+2.5
A sum of public facts, not a judgement and not investment advice.
Competitors
Gerostate AlphaShared: therapeutics, diseaseYC S18San FranciscoStartup →
Origami Therapeutics, Inc.Shared: therapeutics, disorder, indicationYC W22San DiegoStartup →
SynsoryBioShared: therapeutics, disorder, diseaseYC W24BostonStartup →
Dorian TherapeuticsShared: therapeutics, diseaseYC S18San FranciscoStartup →
GEn1E LifesciencesShared: inflammatory, indication, diseaseYC S19San FranciscoStartup →
| Company | Category | Status | Program |
|---|---|---|---|
| Gerostate AlphaShared: therapeutics, diseaseYC S18InactiveOther | Other | Inactive | YCS18 |
| Other | Active | YCW22 | |
| Other | Active | YCW24 | |
| Other | Acquired | YCS18 | |
| AI | Active | YCS19 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCS22 | |
| Other | Active | YCW20 | |
| Other | Active | YCW24 | |
| AI | Active | YCW25 | |
| Other | Active | YCW22 |
Also from S21
All of S21About Promakhos Therapeutics
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
- YC batch
- S21 · Summer 2021
- Status, per YC
- Active
- Category
- Other
- Team size
- 2
- Location
- Boston, MA, USA
- Checked
- 7h ago
YC tags: Therapeutics
Promakhos Therapeutics: questions
Which YC batch was Promakhos Therapeutics in?
Promakhos Therapeutics was in Y Combinator's Summer 2021 batch (S21).
Is Promakhos Therapeutics still active?
Y Combinator lists Promakhos Therapeutics as active.
Where is Promakhos Therapeutics based?
Promakhos Therapeutics lists Boston, MA, USA as its location on YC's directory.